Avaxia Receives $11.4 Mln in Series B Financing
Avaxia Biologics, a Lexington, MA-based biopharmaceutical company, said on Friday that the company has completed $11.4 million in Series B financing. Lead investors were Cherrystone Angels and Golden Seeds. Also participating in the round were new investors AbbVie Inc., Ariel Southeast Angel Partners and Tech Coast Angels as well as existing investors Beacon Angels, Boston Harbor Angels, Launchpad Venture Group, Mass Medical Angels, North Country Angels, the Beta Fund, Granite State Angels, the Keiretsu Forum and Maine Angels.
7 June 2013•3 mins read
